IP Library Assignment 035767/0494
Patent Assignment
Reel/Frame 035767/0494

Merger

Recorded: 2015-06-02 Pages: 5
Assignor
MEDAREX, L.L.C.
Executed: 2014-09-30
Assignee
E. R. SQUIBB & SONS, L.L.C.
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NEW JERSEY, 08540
Covered Properties (13)
Human Anti-Opgl Neutralizing Antibodies as Selective Opgl Pathway Inhibitors
Patent: 7,718,776 →
Application: 10/408,901 →
Publication: US 2004/0023313
Human Anti-Ifn-Gamma Neutralizing Antibodies as Selective Ifn-Gamma Pathway Inhibitors
Patent: 7,335,743 →
Application: 10/684,957 →
Publication: US 2005/0004353
Human Anti-Ngf Neutralizing Antibodies as Selective Ngf Pathway Inhibitors
Patent: 7,601,818 →
Application: 10/891,658 →
Publication: US 2005/0074821
Human Anti-B7RP1 Neutralizing Antibodies
Patent: 7,868,140 →
Application: 11/458,260 →
Publication: US 2008/0166352
Nucleic Acids Encoding Human Anti-Ngf Neutralizing Antibodies as Selective Ngf Pathway Inhibitors
Patent: 7,795,413 →
Application: 11/767,326 →
Publication: US 2008/0033157
Human Anti-Ifn-Gamma Neutralizing Antibodies as Selective Ifn-Gamma Pathway Inhibitors
Patent: 7,790,859 →
Application: 11/962,594 →
Publication: US 2008/0107655
Human Anti-Ngf Neutralizing Antibodies as Selective Ngf Pathway Inhibitors
Patent: 8,198,410 →
Application: 12/277,919 →
Publication: US 2009/0155274
Human Anti-Opgl Neutralizing Antibodies as Selective Opgl Pathway Inhibitors
Patent: 8,367,063 →
Application: 12/782,376 →
Publication: US 2011/0052604
Nucleic Acid Molecules That Encode Human Anti-Ifn-Gamma Neutralizing Antibodies as Selective Ifn-Gamma Pathway Inhibitors
Patent: 8,202,976 →
Application: 12/831,087 →
Publication: US 2011/0045537
Human Anti-Ngf Neutralizing Antibodies as Selective Ngf Pathway Inhibitors
Patent: 8,106,167 →
Application: 12/859,246 →
Publication: US 2011/0040076
Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway Inhibitors
Patent: 8,455,629 →
Application: 13/360,454 →
Publication: US 2012/0156725
Methods for Treating Ifn-Gamma Mediated Diseases Using Human Anti-Ifn-Gamma Neutralizing Antibodies as Selective Ifn-Gamma Pathway Inhibitors
Patent: 8,529,893 →
Application: 13/476,317 →
Publication: US 2012/0269819
Human Anti-IFN-gamma Neutralizing Antibodies as Selective IFN-gamma Pathway Inhibitors
Patent: 8,906,371 →
Application: 13/966,185 →
Publication: US 2014/0004127
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 17, 2012
From: WELCHER, ANDREW A.; CHUTE, HILARY T.; LI, LUKE; HUANG, HAICHUN
To: AMGEN INC.
Reel/Frame 028229/0279 →
Assignment of Assignor's Interest May 17, 2012
From: AMGEN INC.
To: MEDAREX, INC.
Reel/Frame 028229/0337 →
Merger Aug 15, 2013
From: MEDAREX, INC.
To: MEDAREX, L.L.C.
Reel/Frame 031016/0678 →
Assignment of Assignor's Interest Jan 4, 2014
From: WELCHER, ANDREW A.; CHUTE, HILARY T.; LI, LUKE; HUANG, HAICHUN
To: AMGEN INC.
Reel/Frame 031870/0982 →
Assignment of Assignor's Interest Jan 4, 2014
From: AMGEN INC.
To: MEDAREX, INC.
Reel/Frame 031871/0021 →
Merger Jan 27, 2014
From: MEDAREX, INC.
To: MEDAREX, L.L.C.
Reel/Frame 032049/0357 →
Merger Sep 23, 2014
From: MEDAREX, INC.
To: MEDAREX, L.L.C.
Reel/Frame 033796/0759 →
Change of Name Nov 4, 2014
From: MEDAREX, L.L.C.
To: E.R. SQUIBB & SONS, L.L.C.
Reel/Frame 034096/0880 →